PMID: 18707569Aug 19, 2008Paper

Why we need a national registry in interventional cardiology

The Medical Journal of Australia
Ian A Scott

Abstract

Percutaneous coronary intervention (PCI) is increasingly used in the management of acute coronary syndromes and refractory angina, and technical advances such as drug-eluting stents (DES) and potent antithrombotic therapies (such as clopidogrel and glycoprotein IIb/IIIa inhibitors) have been heralded as improving long-term outcomes. Offsetting these advances has been: considerable concern about the safety of DES in regard to late stent thrombosis and antithrombotic drug-induced bleeding; the rising use of PCI and DES in clinical situations where evidence of efficacy is lacking; preferential use of PCI in low-risk populations; and limited cost-effectiveness data comparing PCI with other treatments. There are few contemporary data in Australia on the efficacy, safety and costs of PCI--as used in everyday clinical practice--that matches clinical outcomes with baseline patient characteristics, indications for intervention, coronary anatomy, procedural technique, co-interventions and site of care. A national registry that prospectively collects standardised data on processes and outcomes of PCI is warranted. This would ensure safe and appropriate evidence-based use of limited resources in an era of expanding use of PCI in clinical c...Continue Reading

References

Oct 17, 2002·JAMA : the Journal of the American Medical Association·Elizabeth M MahoneyUNKNOWN TACTICS-TIMI 18 Investigators. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative St
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Nov 9, 2005·The Medical Journal of Australia·Sarah J LordJohn J Atherton
Dec 15, 2005·Heart, Lung & Circulation·A M Tonkin
Dec 31, 2005·The New England Journal of Medicine·Anthony H GershlickUNKNOWN REACT Trial Investigators
Oct 4, 2006·The Medical Journal of Australia·Bryan P YanDavid J Clark
Nov 16, 2006·The New England Journal of Medicine·Judith S HochmanUNKNOWN Occluded Artery Trial Investigators
Dec 7, 2006·JAMA : the Journal of the American Medical Association·Eric L EisensteinRobert M Califf
Dec 19, 2006·Journal of the American College of Cardiology·Matthias PfistererUNKNOWN BASKET-LATE Investigators
Feb 14, 2007·The New England Journal of Medicine·Laura MauriDonald E Cutlip
Feb 14, 2007·The New England Journal of Medicine·Bo LagerqvistUNKNOWN SCAAR Study Group
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Mar 30, 2007·The Medical Journal of Australia·Richard W Harper
May 10, 2007·JAMA : the Journal of the American Medical Association·Nirat BeoharDavid O Williams
May 10, 2007·JAMA : the Journal of the American Medical Association·Htut K WinUNKNOWN EVENT Registry Investigators
Jul 20, 2007·The Cochrane Database of Systematic Reviews·M CucheratG Tremeau
Aug 19, 2007·Archives of Internal Medicine·Grace A LinRita F Redberg
Oct 5, 2007·The New England Journal of Medicine·Jack V TuRon Goeree
Jan 25, 2008·The New England Journal of Medicine·Oscar C MarroquinKevin E Kip
Apr 23, 2008·Circulation·Laura Mauri, Sharon-Lise T Normand
Jun 26, 2008·JAMA : the Journal of the American Medical Association·David J MalenkaJonathan S Skinner

❮ Previous
Next ❯

Citations

Apr 8, 2011·The Medical Journal of Australia·Sue M EvansJohn J McNeil
Mar 6, 2010·The Medical Journal of Australia·John J McNeilPeter A Cameron
Feb 11, 2009·The Medical Journal of Australia·Christopher M ReidDavid Eccleston

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.